← Eichor
Study identifier: NCT05293834 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Virtual Reality Aggression Prevention Training (VRAPT) for (Forensic) Psychiatric Patients

Condition: Forensic Psychiatry  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseNA
Planned participants68
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

Violent and aggressive behavior as well as disorders related to aggressive behavior are highly common in both adult and juvenile forensic psychiatric patients, and is also present in a subgroup of non-forensic psychiatric in- and out-patients. One promising new treatment option is Virtual Reality. A newly developed program in this area is the Virtual Reality Aggression Prevention Training (VRAPT). The purpose of the current feasibility and pilot study is to test VRAPT in a Swiss forensic and non-forensic psychiatric setting, including both adult and juvenile patients, and to examine whether VRAPT is an effective treatment method for aggressive behavior.

This description comes directly from the study's public registry record.

Talk to the study team

Cyril Boonmann, PhD  ·  +41 61 325 82 91  ·  cyril.boonmann@upk.ch

Henning Hachtel, PD. Dr. med.  ·  +41 61 325 51 11  ·  henning.hachtel@upk.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Psychiatric University Hospitals (UPK) BaselBasel, Canton of Basel-City, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05293834